Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension.
Ekkehard GrünigFranck RahaghiJean ElwingCarmine Dario VizzaJoanna Pepke-ZabaJieyan ShenHua YaoAntoine HageStephan RosenkranzMadelon VonkVijay BalasubramanianYang YuanhuaZaixin YuJames LordanLinda CadaretRob GroverAliou OusmanouScott SeamanChunqin DengMeredith BroderickR James Whitenull nullPublished in: Advances in therapy (2023)
ClinicalTrials.gov identifier NCT01560637.